Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy

AIMS: Doxorubicin is used in classical chemotherapy for several cancer types. Doxorubicin-induced cardiomyopathy (DOX-CM) is a critical issue among cancer patients. However, differentiating the diagnosis of DOX-CM from that of other cardiomyopathies is difficult. Therefore, in this study, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Tatsuya, Shiba, Mikio, Ikeda, Yoshihiko, Ohta-Ogo, Keiko, Kondo, Takumi, Tabata, Tomoka, Oka, Toru, Shioyama, Wataru, Yamamoto, Hironori, Yasui, Taku, Higuchi, Yoshiharu, Ishibashi-Ueda, Hatsue, Honma, Keiichiro, Izumi, Chisato, Higo, Shuichiro, Hatakeyama, Kinta, Sakata, Yasushi, Fujita, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613965/
https://www.ncbi.nlm.nih.gov/pubmed/37908440
http://dx.doi.org/10.1093/ehjopen/oead104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613965/
https://www.ncbi.nlm.nih.gov/pubmed/37908440
http://dx.doi.org/10.1093/ehjopen/oead104

Ejemplares similares